Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2021

Feb 24, 2021

32853_dirs_2021-02-23_53d5585a-9513-4ca1-bb0f-e14c3d5981ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2021-02-20

Reporting Person: Linthwaite Stephen Christopher (President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-20 Common Stock M 3167 Acquired 150594 Direct
2021-02-20 Common Stock M 7813 Acquired 158407 Direct
2021-02-20 Common Stock M 6882 Acquired 165289 Direct
2021-02-20 Common Stock M 30888 Acquired 196177 Direct
2021-02-20 Common Stock A 64609 Acquired 260786 Direct
2021-02-20 Common Stock F 57705 $6.12 Disposed 203081 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-20 Restricted Stock Units $ M 3167 Disposed Common Stock (3167.0) Direct
2021-02-20 Restricted Stock Units $ M 7813 Disposed Common Stock (7813.0) Direct
2021-02-20 Restricted Stock Units $ M 6882 Disposed Common Stock (6882.0) Direct
2021-02-20 Restricted Stock Units $ M 30888 Disposed Common Stock (30888.0) Direct

Footnotes

F1: Includes 2,080 shares purchased on November 30, 2020 under the Company's 2017 Employee Stock Purchase Plan.

F2: Represents shares acquired as a result of the certification of the performance condition for performance-based Restricted Stock Units granted on March 19, 2018.

F3: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F4: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter.

F5: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter.

F6: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F7: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.